These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29494768)

  • 1. Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization.
    Doornbos MLJ; Wang X; Vermond SC; Peeters L; Pérez-Benito L; Trabanco AA; Lavreysen H; Cid JM; Heitman LH; Tresadern G; IJzerman AP
    J Med Chem; 2019 Jan; 62(1):223-233. PubMed ID: 29494768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
    Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
    Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.
    Pérez-Benito L; Doornbos MLJ; Cordomí A; Peeters L; Lavreysen H; Pardo L; Tresadern G
    Structure; 2017 Jul; 25(7):1153-1162.e4. PubMed ID: 28648611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222.
    Doornbos ML; Pérez-Benito L; Tresadern G; Mulder-Krieger T; Biesmans I; Trabanco AA; Cid JM; Lavreysen H; IJzerman AP; Heitman LH
    Br J Pharmacol; 2016 Feb; 173(3):588-600. PubMed ID: 26589404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The computational modeling of allosteric modulation of metabotropic glutamate receptors.
    Pérez-Benito L; Llinas Del Torrent C; Pardo L; Tresadern G
    Adv Pharmacol; 2020; 88():1-33. PubMed ID: 32416864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Pharmacology and Binding of mGlu
    O'Brien DE; Shaw DM; Cho HP; Cross AJ; Wesolowski SS; Felts AS; Bergare J; Elmore CS; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2018 May; 93(5):526-540. PubMed ID: 29545267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2.
    Farinha A; Lavreysen H; Peeters L; Russo B; Masure S; Trabanco AA; Cid J; Tresadern G
    Br J Pharmacol; 2015 May; 172(9):2383-96. PubMed ID: 25571949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the molecular logic of a metabotropic glutamate receptor heterodimer.
    Lin X; Provasi D; Niswender CM; Asher WB; Javitch JA
    Nat Commun; 2024 Oct; 15(1):8552. PubMed ID: 39362861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
    Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
    Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
    Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
    Lindsley CW; Emmitte KA; Hopkins CR; Bridges TM; Gregory KJ; Niswender CM; Conn PJ
    Chem Rev; 2016 Jun; 116(11):6707-41. PubMed ID: 26882314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators.
    Tresadern G; Cid JM; Trabanco AA
    J Mol Graph Model; 2014 Sep; 53():82-91. PubMed ID: 25086773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.
    Wu H; Wang C; Gregory KJ; Han GW; Cho HP; Xia Y; Niswender CM; Katritch V; Meiler J; Cherezov V; Conn PJ; Stevens RC
    Science; 2014 Apr; 344(6179):58-64. PubMed ID: 24603153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants.
    Harpsøe K; Isberg V; Tehan BG; Weiss D; Arsova A; Marshall FH; Bräuner-Osborne H; Gloriam DE
    Sci Rep; 2015 Sep; 5():13869. PubMed ID: 26359761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors.
    Rovira X; Malhaire F; Scholler P; Rodrigo J; Gonzalez-Bulnes P; Llebaria A; Pin JP; Giraldo J; Goudet C
    FASEB J; 2015 Jan; 29(1):116-30. PubMed ID: 25342125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.
    Dhanya RP; Sheffler DJ; Dahl R; Davis M; Lee PS; Yang L; Nickols HH; Cho HP; Smith LH; D'Souza MS; Conn PJ; Der-Avakian A; Markou A; Cosford ND
    J Med Chem; 2014 May; 57(10):4154-72. PubMed ID: 24735492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.